About Us

The Oncology Care Organization

Board of Directors: Yawar Mushtaq, Paul Rizzo, Eugene Politano.

Dear Friends,

At Oncology Care, our mission is to provide chemotherapy patients
who are undergoing cancer treatment with free wigs. Why? Because
we have seen and witnessed these patients having the need for it.
When I had visited the cancer centers at the Queens Hospital Center
and Staten Island University Hospital, both of which are in New York,
I came across several women who were undergoing chemotherapy
and had lost all of their hair. Being diagnosed with cancer is alone a
very scary and stressful event, and to add to that stress, anxiety, and
other symptoms of depression, a person who has had long hair since
over 30+ years in most cases, has now lost all of it. We at Oncology
Care want to be present and serve our communities with support that
this great organization provides.

I am very privileged and honored to have a great team of board
members who share the same vision, and are intelligent individuals
who are passionate about serving the community. We all have the
same goals, and most importantly the same mission. Our mission is
strong as we all currently have extensive background and knowledge
in the pharmaceutical/medical industries, which helps to continue our
mission in helping support chemotherapy patients.

I welcome you to explore the Oncology Care Organization, and I
request that you help support us in our efforts to provide support for
cancer patients. And if you know of someone who may require the

services from our Free Wigs Network Program, please have them fill
out the appropriate form or have them contact us. We understand it
may be difficult for cancer patients to contact us directly themselves,
therefore if they prefer someone else contact us on their behalf, we
will do whatever we can to help support them with our services.

I thank you very much for your support and believing in the mission
and value Oncology Care brings to cancer patients.

Sincerely,

Yawar Mushtaq
Oncology Care

Comments are closed.